As part of activities to mark the 2021 World Antimicrobial Awareness Week, Pfizer – a global drug maker has convened experts in the healthcare sector in the country to raise awareness.
According to the global drug manufacturer, governments and the public health community must work together with industry to take further action and support measures that will enable continued innovation in the development of new antibiotics and vaccines to help curb the spread of AMR.
AMR is a silent threat not just in Nigeria but globally and it urgently needs to be addressed, experts have said.
AMR occurs when disease agents such as bacteria, viruses, fungi, and parasites no longer respond to the antimicrobials they once were susceptible to.
According to experts, the silent killer, AMR, is one of the biggest threats to global health today. Today, it accounts for 700,000 deaths annually, and by 2050 it could take 10 million lives globally each year – more than currently die from cancer.
Speaking on the dangers of AMR, besides what can be done to address and prevent AMR. AMR occurs when antibiotics lose their effectiveness as pathogens find ways to resist their effects.
Abdulrazaq Garba Habib, professor of medicine and consultant physician of infectious & tropical diseases, and provost, College of Health Sciences, Department of Medicine Bayero University Kano (BUK) said that antimicrobial medicines are amongst the most precious medical resources the world has ever known. Alarmingly, they are losing their effectiveness.
Read also: Abiru continues Covid-19 financial aid to 2,500 venerable constituents
“With especially low awareness among the public on the dangers of AMR, it is our responsibility as the medical community to educate patients about the condition. Much like COVID-19, AMR pathogens can spread far and with speed, impacting people of all ages.
“There is a significant need for strong public health and prevention measures and extensive surveillance to help curb its spread,” he said.
Also commenting Aaron Oladipo Aboderin, a professor said that with a high cost to individual health and the wider economy, AMR is a critical risk if left unaddressed.
“Should AMR pathogens spread the way COVID-19 has, we will be facing another public health crisis. Today’s roundtable and similar forums are essential to raising awareness of the threats facing us if we do not invest in the development of medicines now to help prevent AMR.”
Since 2017, the World Antibiotic Awareness Week has been used by all sectors to create awareness on AMR with various stakeholders in human health, animals, and the environment engaged.
“AMR if left unchecked could lead to a scenario in which minor infections become life-threatening, while serious infections become impossible to treat, ” said Kodjo Soroh, medical director East & Anglo West Africa Pfizer.
Soroh added that despite the many challenges associated with developing anti-infective, at Pfizer, we remain committed to our R&D efforts to deliver new and effective anti-infective therapies which target newly emerging and difficult to treat infections.
“Despite this, Pfizer remains committed to patients suffering from infectious diseases. In 2020 alone, 28 million patients were treated with a Pfizer anti-infective therapy – a number we expect to grow in the future.”
The COVID-19 pandemic has been a stark reminder of the social and economic hardships of infectious diseases. It reinforces the continuous need for new innovations and breakthroughs.
